0001140361-23-039937.txt : 20230815 0001140361-23-039937.hdr.sgml : 20230815 20230815180213 ACCESSION NUMBER: 0001140361-23-039937 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230811 FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunter Heidi CENTRAL INDEX KEY: 0001891841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 231176001 MAIL ADDRESS: STREET 1: C/O SUTRO BIOPHARMA, INC. STREET 2: 310 UTAH AVE., SUITE 150 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 form4.xml X0508 4 2023-08-11 0001865494 IO Biotech, Inc. IOBT 0001891841 Hunter Heidi C/O IO BIOTECH, INC. OLE MAALOES VEJ 3 COPENHAGEN G7 2200 DENMARK true false Stock Option (Right to Buy) 1.83 2023-08-11 4 A 0 64238 0 A 2033-08-11 Common Stock 64238 64238 D 1/36th of these options vest each month over three years, subject to the reporting person's continued service through each applicable vesting date, and subject to 100% acceleration upon a change of control. /s/ Brian Burkavage, Attorney-in-Fact for Heidi Hunter 2023-08-15